Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: Systematic review and meta-analysis

Tropical Medicine and International Health

Volumn 17, Issue 12, 2012, Pages 1509-1520

  Mugglin, Catrina ^a   Estill, Janne ^a   Wandeler, Gilles ^a,b   Bender, Nicole ^a   Egger, Matthias ^a,c   Gsponer, Thomas ^a   Keiser, Olivia ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Linkage to care; Loss to follow up; Mortality; Pre ART; Sub Saharan Africa

Indexed keywords

DATABASE; DISEASE TREATMENT; HEALTH CARE; HEALTH SERVICES; HUMAN IMMUNODEFICIENCY VIRUS; META-ANALYSIS; MORTALITY; SOCIOECONOMIC STATUS; TEMPORAL PERIOD;

AFRICA; ARTICLE; CD4 LYMPHOCYTE COUNT; DATA BASE; EMBASE; FOLLOW UP; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT MONITORING; SOCIAL STATUS; SYSTEMATIC REVIEW;

ÁFRICA SUBSAHARIANA; AFRIQUE SUBSAHARIENNE; LIENS AVEC LES SOINS; LINKAGE TO CARE; LOSS TO FOLLOW-UP; MORTALIDAD; MORTALITÉ; MORTALITY; NEXO CON ATENCIÓN MÉDICA; PÉRDIDA DURANTE EL SEGUIMIENTO; PERTE AU SUIVI; PRÉ-ART; PRE-ART; PRE-TAR; SUB-SAHARAN AFRICA;

ADULT; AFRICA SOUTH OF THE SAHARA; AIDS SERODIAGNOSIS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; MALE; SEX DISTRIBUTION;

SUB-SAHARAN AFRICA;

EID: 84869868029     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2012.03089.x     Document Type: Article

References (47)

1. Amuron B, Namara G, Birungi J et al. (2009) Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health9, 290.
2. Bassett IV, Wang B, Chetty S et al. (2009) Loss to care and death before antiretroviral therapy in Durban, South Africa. Journal of Acquired Immune Deficiency Syndromes51, 135-139.
3. Bassett IV, Regan S, Chetty S et al. (2010) Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should. AIDS24, S37-S44.
4. Boyles TH, Wilkinson LS, Leisegang R & Maartens G (2011) Factors influencing retention in care after starting antiretroviral therapy in a rural South african programme. PLoS One6, e19201.
5. Braitstein P, Brinkhof MW, Dabis F et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. The Lancet367, 817-824.
6. Brinkhof MW, Pujades-Rodriguez M & Egger M (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One4, e5790.
7. Cornell M, Myer L, Kaplan R, Bekker LG & Wood R (2009) The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Tropical Medicine & International Health14, 722-731.
8. Ekouevi DK, Balestre E, Ba-Gomis FO et al. (2010) Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa. Tropical Medicine & International Health15, 34-42.
9. Faal M, Naidoo N, Glencross DK, Venter WD & Osih R (2011) Providing immediate CD4 count results at HIV testing improves ART initiation. Journal of Acquired Immune Deficiency Syndromes58, e54-e59.
10. Fairall LR, Bachmann MO, Louwagie GM et al. (2008) Effectiveness of antiretroviral treatment in a South African program: a cohort study. Archives of Internal Medicine168, 86-93.
11. Geng EH, Bwana MB, Kabakyenga J et al. (2010) Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda. PLoS One5, e14098.
12. Gilks CF, Crowley S, Ekpini R et al. (2006) The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. The Lancet368, 505-510.
13. Govindasamy D, van Schaik N, Kranzer K, Wood R, Mathews C & Bekker LG (2010) Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata. Journal of Acquired Immune Deficiency Syndromes58, 344-352.
14. Higgins JP, Thompson SG, Deeks JJ & Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ327, 557-560.
15. Ingle SM, May M, Uebel K et al. (2010) Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study. AIDS24, 2717-2725.
16. Jani IV, Sitoe NE, Alfai ER et al. (2011) Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. The Lancet378, 1572-1579.
17. Kaplan R, Orrell C, Zwane E, Bekker LG & Wood R (2008) Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS22, 1679-1681.
18. Keiser O, Anastos K, Schechter M et al. (2008) Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Tropical Medicine & International Health13, 870-879.
19. Kigozi IM, Dobkin LM, Martin JN et al. (2009) Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes52, 280-289.
20. Kohler PK, Chung MH, McGrath CJ, Benki-Nugent SF, Thiga JW & John-Stewart GC (2011) Implementation of free cotrimoxazole prophylaxis improves clinic retention among antiretroviral therapy-ineligible clients in Kenya. AIDS25, 1657-1661.
21. Kranzer K, Zeinecker J, Ginsberg P et al. (2010) Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS One5, e13801.
22. Larson BA, Brennan A, McNamara L et al. (2010a) Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Tropical Medicine & International Health15, 43-47.
23. Larson BA, Brennan A, McNamara L et al. (2010b) Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bulletin of the World Health Organization88, 675-680.
24. Lawn SD, Myer L, Orrell C, Bekker LG & Wood R (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS19, 2141-2148.
25. Lawn SD, Myer L, Harling G, Orrell C, Bekker LG & Wood R (2006) Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clinical Infectious Diseases43, 770-776.
26. Lessells RJ, Mutevedzi PC, Cooke GS & Newell ML (2011) Retention in HIV Care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. Journal of Acquired Immune Deficiency Syndromes56, e79-e86.
27. Losina E, Bassett IV, Giddy J et al. (2010) The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One5, e9538.
28. Loubiere S, Boyer S, Protopopescu C et al. (2009) Decentralization of HIV care in Cameroon: increased access to antiretroviral treatment and associated persistent barriers. Health Policy92, 165-173.
29. Makombe SD, Jahn A, Tweya H et al. (2007) A national survey of teachers on antiretroviral therapy in Malawi: access, retention in therapy and survival. PLoS One2, e620.
30. Maskew M, MacPhail P, Menezes C & Rubel D (2007) Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. South African Medical Journal97, 853-857.
31. May M, Boulle A, Phiri S et al. (2010) Prognosis of patients with HIV-1-infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. The Lancet376, 449-457.
32. McGrath N, Glynn JR, Saul J et al. (2010) What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi. BMC Public Health10, 601.
33. McGuire M, Munyenyembe T, Szumilin E et al. (2010) Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Tropical Medicine & International Health15, 55-62.
34. Micek MA, Gimbel-Sherr K, Baptista AJ et al. (2009) Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. Journal of Acquired Immune Deficiency Syndromes52, 397-405.
35. Mulissa Z, Jerene D & Lindtjørn B (2010) Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia. PLoS One5, e13268.
36. Murphy RA, Sunpath H, Taha B et al. (2010) Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa. International Journal of Tuberculosis and Lung Disease14, 903-908.
37. Ochieng-Ooko V, Ochieng D, Sidle JE et al. (2010) Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bulletin of the World Health Organization88, 681-688.
38. Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, De Azevedo V & Meintjes G (2011) Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa. PLoS One6, e19484.
39. Rosen S & Fox MP (2011) Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Medicine8, e1001056.
40. Scott V, Zweigenthal V & Jennings K (2011) Between HIV diagnosis and initiation of antiretroviral therapy: assessing the effectiveness of care for people living with HIV in the public primary care service in Cape Town, South Africa. Tropical Medicine & International Health16, 1384-1391.
41. Tayler-Smith K, Zachariah R, Massaquoi M et al. (2010) Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system?Transactions of the Royal Society of Tropical Medicine and Hygiene104, 313-319.
42. Tayler-Smith K, Zachariah R, Manzi M et al. (2011) Demographic characteristics and opportunistic diseases associated with attrition during preparation for antiretroviral therapy in primary health centres in Kibera, Kenya. Tropical Medicine & International Health16, 579-584.
43. Togun T, Peterson I, Jaffar S et al. (2011) Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa. AIDS Research and Therapy8, 24.
44. Van der Borght SF, Clevenbergh P, Rijckborst H et al. (2009) Mortality and morbidity among HIV type-1-infected patients during the first 5years of a multicountry HIV workplace programme in Africa. Antiviral Therapy14, 63-74.
45. World Health Organisatio (2011) HIV treatment reaching 6.6 million people, but majority still in need. News release June 2011. http://www.who.int/mediacentre/news/releases/2011/hivtreatement_20110603/en/index.html (accessed 6 August 2012).
46. Zachariah R, Harries AD, Manzi M et al. (2006) Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One1, e121.
47. Zachariah R, Tayler-Smith K, Manzi M et al. (2011) Retention and attrition during the preparation phase and after start of antiretroviral treatment in Thyolo, Malawi, and Kibera, Kenya: implications for programmes?Transactions of the Royal Society of Tropical Medicine and Hygiene105, 421-430.